St. Jude Medical, Inc. announced May 15 U.S. Food and Drug Administration (FDA) clearance of the EnSite System Version 6 software, which provides improved clinical capabilities for cardiac mapping and navigation during electrophysiology (EP) procedures.
St. Jude Medical
Simplifying Global Compliance
Recommended Products
EU MDR Compliance: A Checklist for Meeting Manufacturing, Safety and Performance Requirements
The FDAnews report EU MDR Compliance can help. Our editors have combed through the regulations, picking out the most minute compliance points and building them into a checklist of 200+ requirements you can use to confirm that you are satisfying all the EU mandates for device manufacturing.
Accelerating Generic Drug Development: The FDA’s New Plan for Increasing Generic Competition
Accelerating Generic Drug Development explains the FDA’s new policy and shows how to navigate the new pathway to approval.
Editor's Picks
BSI Warns Devicemakers to Migrate CE Certificates Before Brexit Deadline
BSI said that when it initiated its contingency plan in August 2016, it “could not have foreseen the lack of political progress” toward a Brexit resolution.
Democrats Introduce Price Gouging Bill
Brown and Gillibrand said the money from fines would be used for drug research and development.
FDAnews Device Daily Bulletin
ST. JUDE MEDICAL ANNOUNCES FDA CLEARANCE OF ENSITE SYSTEM 6 SOFTWARE FOR CARDIAC MAPPING AND NAVIGATION
May 18, 2006
